Evidence map›Paper›PMID 35264214›Full record

ReviewItalian journal of pediatrics2022

Italian intersociety consensus on management of long covid in children.

Susanna Esposito, Nicola Principi, Chiara Azzari, Fabio Cardinale, Giuseppe Di Mauro, Luisa Galli, Guido Castelli Gattinara, Valentina Fainardi, Alfredo Guarino, Laura Lancella and 9 more

Open access · goldAbstract readReviewConsensus Statement
In one paragraph

Review in Italian journal of pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Post-Covid-19 Symptoms in Children: A Cross-Sectional Survey.Journal of paediatrics and child health · 2025
    Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Year 2022: exploring COVID-19 pandemic in children.Italian journal of pediatrics · 2023
    Review
  19. Article
  20. Navigating paediatric virology through the COVID‑19 era (Review).International journal of molecular medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 12 institutions in 1 country.

Susanna EspositoPietro Barilla Children's Hospital, Pediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Via Gramsci 14, 43126, Parma, Italy. susannamariaroberta.esposito@unipr.it.ORCID http://orcid.org/0000-0003-4103-2837
Nicola PrincipiUniversità degli Studi di Milano, Milan, Italy.
Chiara AzzariDepartment of Health Sciences, Section of Pediatrics, University of Florence, Florence, Italy.
Fabio CardinalePediatric and Emergency Unit Giovanni XXIII Pediatric Hospital, University of Bari, Bari, Italy.
Giuseppe Di MauroFamily Paediatrician, Local Health Unit, Caserta, Italy.
Luisa GalliPaediatric Infectious Disease Unit, Meyer Children's University Hospital, Department of Health Sciences, University of Florence, Florence, Italy.
Guido Castelli GattinaraIRCCS Bambino Gesù Children Hospital, Rome, Italy.
Valentina FainardiPietro Barilla Children's Hospital, Pediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Via Gramsci 14, 43126, Parma, Italy.
Alfredo GuarinoDepartment of Translational Medical Sciences, Section of Pediatrics, University Federico II of Naples, Naples, Italy.
Laura LancellaPaediatric and Infectious Disease Unit, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCSS, Rome, Italy.
Amelia LicariMaternal and Child Department, IRCCS Foundation Policlinico "S. Matteo" di Pavia, Pavia, Italy.
Enrica MancinoDepartment of Maternal, Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.
Gian Luigi MarsegliaMaternal and Child Department, IRCCS Foundation Policlinico "S. Matteo" di Pavia, Pavia, Italy.
Salvatore LeonardiPediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Catania, Italy.
Raffaella NennaDepartment of Maternal, Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.
Stefania ZampognaDepartment of Pediatrics, Pugliese-Ciaccio Hospital of Catanzaro, Catanzaro, Italy.
Stefano ZonaPrimary Health Care Department, Local Health Agency of Modena, Modena, Italy.
Annamaria StaianoDepartment of Translational Medical Sciences, Section of Pediatrics, University Federico II of Naples, Naples, Italy.
Fabio MidullaPediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Catania, Italy.
Bambino Gesù Children's Hospital · ITFederico II University Hospital · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITSapienza University of Rome · ITUniversity of Catania · ITUniversity of Parma · ITAzienda Ospedaliera Pugliese Ciaccio · ITAzienda Unita' Sanitaria Locale Di Modena · ITMeyer Children's Hospital · ITOspedale Pediatrico Giovanni XXIII · ITUniversity of Florence · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTwo sequelae of pediatric COVID-19 have been identified, the multisystem inflammatory syndrome in children (MIS-C) and the long COVID. Long COVID is much less precisely defined and includes all the persistent or new clinical manifestations evidenced in subjects previously infected by SARS-CoV-2 beyond the period of the acute infection and that cannot be explained by an alternative diagnosis. In this Intersociety Consensus, present knowledge on pediatric long COVID as well as how to identify and manage children with long COVID are discussed. MAIN

findingsAlthough the true prevalence of long COVID in pediatrics is not exactly determined, it seems appropriate to recommend evaluating the presence of symptoms suggestive of long COVID near the end of the acute phase of the disease, between 4 and 12 weeks from this. Long COVID in children and adolescents should be suspected in presence of persistent headache and fatigue, sleep disturbance, difficulty in concentrating, abdominal pain, myalgia or arthralgia. Persistent chest pain, stomach pain, diarrhea, heart palpitations, and skin lesions should be considered as possible symptoms of long COVID. It is recommended that the primary care pediatrician visits all subjects with a suspected or a proven diagnosis of SARS-CoV-2 infection after 4 weeks to check for the presence of symptoms of previously unknown disease. In any case, a further check-up by the primary care pediatrician should be scheduled 3 months after the diagnosis of SARS-CoV-2 infection to confirm normality or to address emerging problems. The subjects who present symptoms of any organic problem must undergo a thorough evaluation of the same, with a possible request for clinical, laboratory and / or radiological in-depth analysis in case of need. Children and adolescents with clear symptoms of mental stress will need to be followed up by existing local services for problems of this type.

conclusionsPediatric long COVID is a relevant problem that involve a considerable proportion of children and adolescents. Prognosis of these cases is generally good as in most of them symptoms disappear spontaneously. The few children with significant medical problems should be early identified after the acute phase of the infection and adequately managed to assure complete resolution. A relevant psychological support for all the children during COVID-19 pandemic must be organized by health authorities and government that have to treat this as a public health issue.

Indexed as

COVID-19AdolescentChildHumansPandemicsPost-Acute COVID-19 SyndromeSARS-CoV-2Systemic Inflammatory Response SyndromeCOVID-19Long COVIDMental healthPediatric infectious diseasesSARS-CoV-2

Identifiers

PMID35264214
PMCPMC8905554
OpenAlexW4220663113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.